Name | Number of supported studies | Average coverage | |
---|---|---|---|
regulatory T cell | 16 studies | 25% ± 5% | |
fibroblast | 5 studies | 27% ± 7% | |
epithelial cell | 4 studies | 20% ± 3% | |
T follicular helper cell | 4 studies | 17% ± 3% | |
CD4-positive, alpha-beta memory T cell | 4 studies | 17% ± 1% | |
T cell | 3 studies | 16% ± 1% | |
effector CD4-positive, alpha-beta T cell | 3 studies | 18% ± 1% | |
effector memory CD4-positive, alpha-beta T cell | 3 studies | 18% ± 2% | |
basal cell | 3 studies | 21% ± 3% | |
CD4-positive, alpha-beta T cell | 3 studies | 17% ± 1% |
Insufficient scRNA-seq data for expression of FAS at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
thymus | 99% | 1279.85 | 647 / 653 | 98% | 20.07 | 594 / 605 |
esophagus | 100% | 1122.59 | 1445 / 1445 | 94% | 10.59 | 172 / 183 |
lung | 100% | 3425.23 | 578 / 578 | 93% | 13.57 | 1071 / 1155 |
uterus | 100% | 2223.38 | 170 / 170 | 91% | 14.60 | 419 / 459 |
ovary | 100% | 3311.72 | 180 / 180 | 91% | 9.22 | 392 / 430 |
kidney | 97% | 1091.22 | 86 / 89 | 92% | 18.18 | 831 / 901 |
breast | 100% | 1553.34 | 458 / 459 | 87% | 8.81 | 974 / 1118 |
prostate | 100% | 1501.29 | 244 / 245 | 85% | 7.16 | 428 / 502 |
intestine | 100% | 1350.96 | 966 / 966 | 85% | 8.92 | 446 / 527 |
adrenal gland | 100% | 3485.45 | 258 / 258 | 76% | 9.33 | 174 / 230 |
bladder | 100% | 1304.24 | 21 / 21 | 73% | 7.96 | 368 / 504 |
skin | 99% | 1923.51 | 1796 / 1809 | 69% | 6.43 | 324 / 472 |
liver | 98% | 773.27 | 221 / 226 | 70% | 5.88 | 283 / 406 |
stomach | 68% | 485.35 | 244 / 359 | 85% | 9.57 | 242 / 286 |
pancreas | 45% | 209.07 | 149 / 328 | 96% | 10.92 | 170 / 178 |
brain | 54% | 339.06 | 1435 / 2642 | 62% | 5.80 | 438 / 705 |
spleen | 100% | 1439.96 | 241 / 241 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 1636.92 | 1333 / 1335 | 0% | 0 | 0 / 0 |
adipose | 100% | 1720.63 | 1201 / 1204 | 0% | 0 | 0 / 0 |
peripheral blood | 94% | 2746.42 | 869 / 929 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 93% | 18.36 | 42 / 45 |
lymph node | 0% | 0 | 0 / 0 | 93% | 25.87 | 27 / 29 |
heart | 84% | 658.74 | 725 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 40% | 3.72 | 32 / 80 |
muscle | 23% | 99.66 | 181 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0097191 | Biological process | extrinsic apoptotic signaling pathway |
GO_0071260 | Biological process | cellular response to mechanical stimulus |
GO_0007165 | Biological process | signal transduction |
GO_0001934 | Biological process | positive regulation of protein phosphorylation |
GO_0032872 | Biological process | regulation of stress-activated MAPK cascade |
GO_0065003 | Biological process | protein-containing complex assembly |
GO_0006955 | Biological process | immune response |
GO_0042981 | Biological process | regulation of apoptotic process |
GO_0043066 | Biological process | negative regulation of apoptotic process |
GO_0097192 | Biological process | extrinsic apoptotic signaling pathway in absence of ligand |
GO_2001269 | Biological process | positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway |
GO_0034198 | Biological process | cellular response to amino acid starvation |
GO_0006924 | Biological process | activation-induced cell death of T cells |
GO_0071455 | Biological process | cellular response to hyperoxia |
GO_0097049 | Biological process | motor neuron apoptotic process |
GO_0097527 | Biological process | necroptotic signaling pathway |
GO_0006915 | Biological process | apoptotic process |
GO_2001235 | Biological process | positive regulation of apoptotic signaling pathway |
GO_0043065 | Biological process | positive regulation of apoptotic process |
GO_0036337 | Biological process | Fas signaling pathway |
GO_0033209 | Biological process | tumor necrosis factor-mediated signaling pathway |
GO_0009897 | Cellular component | external side of plasma membrane |
GO_0005886 | Cellular component | plasma membrane |
GO_0045121 | Cellular component | membrane raft |
GO_0070062 | Cellular component | extracellular exosome |
GO_0031265 | Cellular component | CD95 death-inducing signaling complex |
GO_0009986 | Cellular component | cell surface |
GO_0016604 | Cellular component | nuclear body |
GO_0005829 | Cellular component | cytosol |
GO_0031264 | Cellular component | death-inducing signaling complex |
GO_0038023 | Molecular function | signaling receptor activity |
GO_0019900 | Molecular function | kinase binding |
GO_0042802 | Molecular function | identical protein binding |
GO_0005031 | Molecular function | tumor necrosis factor receptor activity |
GO_0005516 | Molecular function | calmodulin binding |
GO_0005515 | Molecular function | protein binding |
Gene name | FAS |
Protein name | Tumor necrosis factor receptor superfamily member 6 (Apo-1 antigen) (Apoptosis-mediating surface antigen FAS) (FASLG receptor) FAS variant Apoptosis signaling receptor FAS FAS 827dupA variant Fas cell surface death receptor FAS receptor variant 9 (Fas cell surface death receptor) Tumor necrosis factor receptor superfamily member 6 (Apo-1 antigen) (Apoptosis-mediating surface antigen FAS) (FASLG receptor) (CD antigen CD95) FAS |
Synonyms | TNFRSF6 FAS1 APT1 |
Description | FUNCTION: Receptor for TNFSF6/FASLG. The adapter molecule FADD recruits caspase CASP8 to the activated receptor. The resulting death-inducing signaling complex (DISC) performs CASP8 proteolytic activation which initiates the subsequent cascade of caspases (aspartate-specific cysteine proteases) mediating apoptosis. FAS-mediated apoptosis may have a role in the induction of peripheral tolerance, in the antigen-stimulated suicide of mature T-cells, or both. The secreted isoforms 2 to 6 block apoptosis (in vitro). . |
Accessions | ENST00000494799.6 ENST00000492756.7 [P25445-5] ENST00000696771.1 A0A8V8TKN4 ENST00000697036.1 [P25445-4] ENST00000696782.1 ENST00000697035.1 ENST00000696780.1 ENST00000696776.1 A0A8Q3WLL4 Q59FU8 P25445 A0A8Q3WLK1 A0A8Q3SJI5 S5PZ57 Q9UET8 A0A8V8TM64 ENST00000697095.1 ENST00000696779.1 A0A8Q3WM13 ENST00000479522.6 [P25445-3] F0UWG7 ENST00000562983.3 ENST00000355279.2 [P25445-7] A0A087WTM9 ENST00000690268.1 ENST00000696768.1 S5PSV7 ENST00000460510.6 ENST00000357339.7 [P25445-6] E6Y7C3 ENST00000696781.1 ENST00000484444.6 [P25445-2] ENST00000696997.1 ENST00000612663.6 ENST00000696999.1 E6Y7C4 A0A8V8TKJ0 ENST00000697097.1 ENST00000488877.6 [P25445-4] ENST00000652046.1 [P25445-1] K9J972 ENST00000477270.6 A0A8Q3SIR6 A0A8Q3WLI5 ENST00000355740.8 A0A8Q3WLK6 ENST00000494410.5 [P25445-4] A0A8Q3SIY4 |